Baby Safety / Compounds / Platinum (and platinum-based catalysts)

Is Platinum (and platinum-based catalysts) safe for babies and kids?

Context-dependent for kids

Infants are more vulnerable to Platinum (and platinum-based catalysts) than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

What is platinum (and platinum-based catalysts)?

The IUPAC name is platinum.

Also known as: platinum, Platinum Black, Platinum sponge, Platinum powder.

IUPAC name: platinum
CAS number: 7440-06-4
Molecular formula: Pt
Molecular weight: 195.08 g/mol
SMILES: [Pt]
PubChem CID: 23939

Risk for babies

Context-dependent

Neonates and infants up to 12 months have incomplete blood-brain barrier development, immature Phase I/II metabolic enzymes (particularly CYP3A4, UGT1A1), and higher gastrointestinal permeability. Equivalent doses produce higher internal concentrations and longer residence times.

What to do: Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

Regulatory consensus

3 regulatory and scientific bodies have classified Platinum (and platinum-based catalysts). The classifications differ — that's the data.

Agency	Year	Classification	Notes
IARC	2006	Platinum (metal, elemental): Group 3 (not classifiable). Soluble platinum(II) and platinum(IV) compounds in animal studies show carcinogenicity signals, but human epidemiology limited.	Elemental platinum classified Group 3; soluble Pt salts (Pt(II)/Pt(IV)) elevated in animal carcinogenicity data but human exposure data sparse
OSHA	2020	Soluble platinum salts: occupational exposure limit 0.002 mg/m³ (8-hr PEL). Elemental platinum dust: 5 mg/m³ (OSHA general dust limit)	Occupational exposure limits reflect hazard in high-exposure settings. Medical device and implant residual platinum not regulated by occupational standards.
FDA	2023	Platinum residue in medical devices (silicone breast implants, catheters, pacemaker leads): no maximum limit established; evaluated as biocompatible on case-by-case basis	Residual platinum from polymerization catalysts in medical devices is not explicitly limited or monitored. FDA relies on biocompatibility testing framework that does not establish specific Pt thresholds.

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where kids encounter platinum (and platinum-based catalysts)

Industrial Facilities — Manufacturing plants, Chemical storage areas, Waste treatment sites
Occupational Environments — Factories, Warehouses, Transportation vehicles

Safer alternatives

Lower-risk approaches that achieve a similar outcome to Platinum (and platinum-based catalysts):

Physical/mechanical pest control (IPM)
Trade-offs: More labor-intensive. May not be sufficient for severe infestations.

Relative cost: 1.2-2×

Frequently asked questions

Is platinum (and platinum-based catalysts) safe for kids?

What products contain platinum (and platinum-based catalysts)?

Platinum (and platinum-based catalysts) appears in: Manufacturing plants (Industrial facilities); Chemical storage areas (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments).

What should I do if my child is exposed to platinum (and platinum-based catalysts)?

Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

Why do regulators disagree about platinum (and platinum-based catalysts)?

Platinum (and platinum-based catalysts) has been classified by 3 agencies including IARC, OSHA, FDA, with differing conclusions. Regulators apply different standards of evidence (animal data weighting, exposure-pattern assumptions, epidemiological power thresholds), which is why two scientific bodies can review the same data and reach different conclusions. See the regulatory consensus table on this page for the full picture.

See Platinum (and platinum-based catalysts) in the baby app

Look up products containing platinum (and platinum-based catalysts), compare to alternatives, and explore the full data record.

Open in baby View raw API data

Sources (7)

In Vivo Oxidation of Residual Platinum(0) Catalyst in Medical-Grade Silicone: Formation of Genotoxic Pt(II/IV) Species (2018) — journal
Soluble Platinum Compounds and DNA Damage: In Vitro and Animal Model Evidence of Genotoxicity (2017) — journal
Platinum Detection in Pericapsular Tissue and Blood of Silicone Breast Implant Recipients (2020) — journal
FDA Guidance for Industry: Biocompatibility Evaluation of Medical Devices (ISO 10993 Standard) (2020) — regulatory
FDA: Medical Device Leachables and Extractables Framework — No Platinum-Specific Limit Established (2022) — regulatory
Urban Environmental Platinum from Vehicle Catalytic Converters: Soil and Dust Contamination Near Major Roads (2019) — journal
Occupational Exposure to Platinum in Catalytic Converter Recycling and Jewelry Manufacturing: Respiratory and Dermal Routes (2021) — journal

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →